Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peripheral Nervous System Diseases × eribulin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 103 Triple Negative Breast Neoplasms 23 Neoplasm Metastasis 17 Sarcoma 14 Neoplasms 14 Ovarian Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Brain Neoplasms 5 Prostatic Neoplasms 4 Liposarcoma 3 Inflammatory Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Recurrence 2 Pancreatic Neoplasms 2 Lymphoma 2 Leiomyosarcoma 2 HER2-negative Breast Cancer 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumors 1 Salivary Gland Neoplasms 1 Relapsed Solid Tumors 1

Interventions

Acupuncture Therapy 7 Cryotherapy 6 Paclitaxel 5 Glutamine 5 Exercise 5 Surveys and Questionnaires 2 Sodium Chloride 2 Saline Solution 2 Physical Therapy Modalities 2 Low-Level Light Therapy 2 Lenalidomide 2 Fish Oils 2 Fatty Acids, Omega-3 2 Acetylcysteine 2 ziconotide 1 nicotinamide-beta-riboside 1 nabilone 1 eribulin 1 Yoga 1 XELOX 1 Vitamin D 1 Vitamin B Complex 1 Vitamin B 6 1 Vitamin B 12 1 Ultrasonic Therapy 1 Trimetazidine 1 Thioctic Acid 1 Therapeutic Touch 1 Taxoids 1 Tadalafil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03027245 2022-07-13

IRENE

Eisai Inc.

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡